1.Aronow, WS, Fleg, JL, Pepine, CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011; 5(4):259–352.
2.Egan, BM, Zhao, Y, Axon, RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010; 303(20):2043–2050.
3.Vasan, RS, Beiser, A, Seshadri, S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002; 287(8):1003–1010.
4.Prys-Roberts, C. Isolated systolic hypertension: pressure on the anaesthetist? Anaesthesia. 2001; 56(6):505–510.
5.Staessen, JA, Fagard, R, Thijs, L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350(9080):757–764.
6.Gasowski, J, Fagard, RH, Staessen, JA, et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens. 2002; 20(1):145–151.
7.SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265(24):3255–3264.
8.Aronson, S, Boisvert, D, Lapp, W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg. 2002; 94(5):1079–1084, table of contents.
9.Karapanayiotides, T, Meuli, R, Devuyst, G, et al. Postcarotid endarterectomy hyperperfusion or reperfusion syndrome. Stroke. 2005; 36(1):21–26.
10.Browner, WS, Li, J, Mangano, DT; The Study of Perioperative Ischemia Research Group. In-hospital and long-term mortality in male veterans following noncardiac surgery. JAMA. 1992; 268(2):228–232.
11.Kheterpal, S, Tremper, KK, Englesbe, MJ, et al. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007; 107(6):892–902.
12.Sear, JW. Perioperative control of hypertension: when will it adversely affect perioperative outcome? Curr Hypertens Rep. 2008; 10(6):480–487.
13.Staessen, JA, Gasowski, J, Wang, JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000; 355(9207):865–872.
14.Perry, HM Jr., Davis, BR, Price, TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000; 284(4):465–471.
15.Beckett, NS, Peters, R, Fletcher, AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358(18):1887–1898.
16.Klingbeil, AU, Schneider, M, Martus, P, Messerli, FH, Schmieder, RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003; 115(1):41–46.
17.Wachtell, K, Bella, JN, Rokkedal, J, et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation. 2002; 105(9):1071–1076.
18.Howell, SJ, Sear, JW, Foex, P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth. 2004; 92(4):570–583.
19.Weksler, N, Klein, M, Szendro, G, et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? J Clin Anesth. 2003; 15(3):179–183.
20.Wang, JG, Staessen, JA. Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension. Drugs Aging. 2001; 18(5):345–353.
21.Kim, BS, Bae, JN, Cho, MJ. Depressive symptoms in elderly adults with hypotension: different associations with positive and negative affect. J Affect Disord. 2010; 127(1–3):359–364.
22.Devereaux, PJ, Yang, H, Yusuf, S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008; 371(9627):1839–1847.
23.Foex, P, Sear, JW. The surgical hypertensive patient. Cont Edu in Anaesth, Crit Care Pain. 2004; 4:139–143.
24.Eagle, KA, Berger, PB, Calkins, H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002; 105(10):1257–1267.
25.Fleisher, LA, Beckman, JA, Brown, KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anes Analg. 2008; 106(3):685–712.
26.Fleisher, LA, Fleischmann, KE, Auerbach, AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 64(22):e77–e137.
27.Goldman, L, Caldera, DL, Nussbaum, SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 297(16):845–850.
28.Lee, TH, Marcantonio, ER, Mangione, CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100(10):1043–1049.
29.Gupta, PK, Gupta, H, Sundaram, A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011; 124(4):381–387.
30.Collaboration BPLTT. Effects of angiotensin converting enzyme inhibitors, calcium antagonists and other blood pressure lowering drugs on mortality and major cardiovascular morbidity: first cycle of analyses from a program of prospectively designed collaborative overviews of major randomised trials. Lancet. 2000; 355(9246):1955–1964.
31.Fleisher, LA. Preoperative evaluation of the patient with hypertension. JAMA. 2002; 287(16):2043–2046.
32.Coriat, P, Richer, C, Douraki, T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology. 1994; 81(2):299–307.
33.Bertrand, M, Godet, G, Meersschaert, K, et al. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg. 2001; 92(1):26–30.
34.Ryckwaert, F, Colson, P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg. 1997; 84(5):945–949.
35.Licker, M, Schweizer, A, Hohn, L, Farinelli, C, Morel, DR. Cardiovascular responses to anesthetic induction in patients chronically treated with angiotensin-converting enzyme inhibitors. Can J Anaesth. 2000; 47(5):433–440.
36.Turan, A, You, J, Shiba, A, et al. Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery. Anesth Analg. 2012; 114(3):552–560.
37.Wijeysundera, DN, Beattie, WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg. 2003; 97(3):634–641.
38.Wijeysundera, DN, Beattie, WS, Rao, V, Karski, J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol. 2003; 41(9):1496–1505.
39.Wildburger, NC, Lin-Ye, A, Baird, MA, Lei, D, Bao, J. Neuroprotective effects of blockers for T-type calcium channels. Mol Neurodegener. 2009; 4:44.
40.Lopez-Arrieta, JM, Birks, J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev. 2002(3):CD000147.
41.Khan, NA, Campbell, NR, Frost, SD, et al. Risk of intraoperative hypotension with loop diuretics: a randomized controlled trial. Am J Med. 2010; 123(11):1059. e1–8.
42.Wallace, AW, Au, S, Cason, BA. Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology. 2010; 113(4):794–805.
43.Shammash, JB, Trost, JC, Gold, JM, et al. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J. 2001; 141(1):148–153.
44.Bell, CM, Hatch, WV, Fischer, HD, et al. Association between tamsulosin and serious ophthalmic adverse events in older men following cataract surgery. JAMA. 2009; 301(19):1991–1996.
45.Milne, B. Alpha-2 agonists and anaesthesia. Can J Anaesth. 1991; 38(7):809–813.
46.Cohn, S. Perioperative Medication Management. London, Springer-Verlag, 2011.
47.Hollevoet, I, Herregods, S, Vereecke, H, Vandermeulen, E, Herregods, L. Medication in the perioperative period: stop or continue? A review. Acta Anaesthesiol Belg. 2011; 62(4):193–201.
48.Taylor, AL, Ziesche, S, Yancy, C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004; 351(20):2049–2057.
49.Xhignesse, P, Saint-Remy, A, Krzesinski, JM. [Management of arterial hypertension in the elderly]. Rev Med Liege. 2014; 69(5-6):294–300.
50.Ogihara, T, Saruta, T, Rakugi, H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010; 56(2):196–202.
51.James, PA, Oparil, S, Carter, BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 311(5):507–520.
52.Arguedas, JA, Leiva, V, Wright, JM. Blood pressure targets for hypertension in people with diabetes mellitus. Cochrane Database Syst Rev. 2013(10):CD008277.
53.Rhoney, D, Peacock, WF. Intravenous therapy for hypertensive emergencies, Part 1. Am J Health Syst Pharm. 2009; 66(15):1343–1352.
54.Young, JH, Klag, MJ, Muntner, P, et al. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002; 13(11):2776–2782.
55.Helfman, SM, Gold, MI, DeLisser, EA, Herrington, CA. Which drug prevents tachycardia and hypertension associated with tracheal intubation: lidocaine, fentanyl, or esmolol? Anesth Analg. 1991; 72(4):482–486.
56.Rose, DK, Cohen, MM, DeBoer, DP. Cardiovascular events in the postanesthesia care unit: contribution of risk factors. Anesthesiology. 1996; 84(4):772–781.
57.Varon, J, Marik, PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008; 4(3):615–627.